Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal (Q37347003)

19 August 2017

1 reference

title

Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal (English)

1 reference

19 August 2017

0 references

M LeBel

1

1 reference

19 August 2017

publication date

1 April 1991

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

316-324

1 reference

Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Pharmacokinetics of ciprofloxacin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967005

Lack of correlation between objective indicators and clinical-response scores during antimicrobial therapy for acute pulmonary exacerbations of cystic fibrosis

21 January 2018

1 reference

12 December 2020

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa

1 reference

12 December 2020

Endobronchial infection in cystic fibrosis.

1 reference

12 December 2020

Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis

1 reference

12 December 2020

Ciprofloxacin: comparative data in cystic fibrosis

1 reference

12 December 2020

Pathogenesis and management of arthropathy in cystic fibrosis

1 reference

12 December 2020

Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection

1 reference

12 December 2020

Ofloxacin in cystic fibrosis.

1 reference

12 December 2020

Use of quinolones in pediatric patients

1 reference

12 December 2020

[A cross-over study on the effectiveness of ofloxacin and ciprofloxacin administered orally]

1 reference

12 December 2020

Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients

1 reference

12 December 2020

High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients

1 reference

12 December 2020

What is a "pulmonary exacerbation" in cystic fibrosis?

1 reference

12 December 2020

Efficacy of Ciprofloxacin in Patients with Cystic Fibrosis

1 reference

12 December 2020

Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?

1 reference

12 December 2020

Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis

1 reference

12 December 2020

Ciprofloxacin therapy in cystic fibrosis

1 reference

12 December 2020

Arthropathy in a patient with cystic fibrosis taking ciprofloxacin

1 reference

12 December 2020

Clinical pharmacokinetics in infants and children. A reappraisal

1 reference

12 December 2020

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

1 reference

12 December 2020

Antibacterial therapy in cystic fibrosis

1 reference

12 December 2020

Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance

1 reference

12 December 2020

Clinical efficacy of ciprofloxacin in lower respiratory tract infections.

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics in patients with cystic fibrosis

1 reference

12 December 2020

Clinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients.

1 reference

12 December 2020

Where are we now with ciprofloxacin?

1 reference

12 December 2020

Quinolone antimicrobial agents: adverse effects and bacterial resistance

1 reference

12 December 2020

Altered disposition of fleroxacin in patients with cystic fibrosis

1 reference

12 December 2020

Antimicrobial chemotherapy in patients with cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics of drugs in cystic fibrosis

1 reference

12 December 2020

Clinical pharmacology of antibiotics and other drugs in cystic fibrosis

1 reference

12 December 2020

Therapeutic management of cystic fibrosis

1 reference

12 December 2020

Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

1 reference

12 December 2020

Ciprofloxacin in cystic fibrosis

1 reference

12 December 2020

Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis

1 reference

12 December 2020

Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis and drug-induced arthropathy

1 reference

12 December 2020

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

1 reference

12 December 2020

Antibiotic use in cystic fibrosis.

1 reference

12 December 2020

[Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis]

1 reference

12 December 2020

Use of ciprofloxacin in cystic fibrosis patients

1 reference

12 December 2020

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin

1 reference

12 December 2020

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

12 December 2020

Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics

1 reference

12 December 2020

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis

1 reference

12 December 2020

The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

12 December 2020

Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis

1 reference

12 December 2020

Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01967005

1 reference

19 August 2017

1 reference